Table 5 Recommendations to promote adoption of NGS in clinical oncology
From: Scenario drafting for early technology assessment of next generation sequencing in clinical oncology
Domain | Recommendation |
|---|---|
Social | ▪ Further investigate patients’ perspective ▪ Organize additional training on pharmacogenomics for physicians. |
Technical | ▪ Use desired technical specifications as a guideline for development of a NGS panel. ▪ Develop user-friendly FFPE-capable NGS panels. |
Reimbursement | ▪ Further investigate willingness-to-pay ▪ Set cost-effectiveness as a high priority to facilitate reimbursement. |
Clinical utility and evidence generation | ▪ Advocate novel evidence generation designs. |
Market access | ▪ Enter the market rapidly to maximize window of opportunity |